Michael J. Morris, Andrew J. Armstrong. "Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer." Journal of Clinical Oncology, 2026. doi:10.1200/jco-26-01356